Consistently, failure to properly regulate GSK3 activity plays a role in Alzheimer’s disease and schizophrenia [70–72], diseases associated with Kidins220 alterations, amongst others [17, 21–28, 72]. This evidence concerns the gene KIDINS220 and schizophrenia.